supp.fit

Artichoke Extract: study protocols

14 study groups say how much Artichoke Extract participants took a day. These are the doses the studies gave. They are not a recommendation.

Artichoke Extract: what the research found →

Dose per serving from products

557 products in our catalogue print how much Artichoke Extract a serving holds.

Most common: 25 mg to 50 mg, 40% of 557 products.

Dose per servingProducts
10 mg or less
19
10 mg to 25 mg
37
25 mg to 50 mg
223
50 mg to 100 mg
106
100 mg to 250 mg
93
250 mg to 500 mg
45
500 mg to 1 g
23
over 1 g
11

Dose per serving from research

14 study groups in 13 studies say how much Artichoke Extract participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 1 g to 2.5 g, 43% of 14 study groups.

Daily doseStudy groups
100 mg to 250 mg
2
250 mg to 500 mg
2
500 mg to 1 g
4
1 g to 2.5 g
6

Commonly used together

2 of 14 study groups took Artichoke Extract with something else, but nothing that 3 or more different studies gave.

14 study groups

Study
Efficacy of artichoke leaf extract in the treatment of patients with functional dyspepsia: a six-week placebo-controlled, double-blind, multicentre trial
2003 · Artichoke leaf extract · Adults with functional dyspepsia
960 mg6 weeks129
Artichoke leaf extract reduces mild dyspepsia in an open study
2002 · 640 mg daily group · Healthy adults with self-reported dyspepsia
640 mg60 days—
Artichoke leaf extract reduces mild dyspepsia in an open study
2002 · 320 mg daily group · Healthy adults with self-reported dyspepsia
320 mg60 days—
Efficacy of artichoke leaf extract in non-alcoholic fatty liver disease: A pilot double-blind randomized controlled trial
2018 · ALE · People with ultrasound-diagnosed non-alcoholic fatty liver disease; age and sex not reported
600 mg60 days49
Beneficial effects of artichoke leaf extract supplementation on increasing HDL-cholesterol in subjects with primary mild hypercholesterolaemia: a double-blind, randomized, placebo-controlled trial
2013 · supplementation · Overweight adults with primary mild hypercholesterolaemia; mean age 54.2 years; 20 men and 26 women
500 mg8 weeks46
Metabolic management in overweight subjects with naive impaired fasting glycaemia by means of a highly standardized extract from Cynara scolymus: a double-blind, placebo-controlled, randomized clinical trial
2014 · Cynara scolymus extract group · Overweight subjects with naïve impaired fasting glycaemia
600 mg8 weeks26
Antioxidant response to artichoke leaf extract supplementation in metabolic syndrome: A double-blind placebo-controlled randomized clinical trial
2018 · ALE group · Patients with metabolic syndrome
1.8 g12 weeks33
The influence of supplementation with artichoke (Cynara scolymus L.) extract on selected redox parameters in rowers
2008 · supplemented group · Competitive rowers on the Polish rowing team; age and sex not specified
1.2 g5 weeks12
Efficacy of Artichoke dry extract in patients with hyperlipoproteinemia
2000 · artichoke dry extract group · Adults with hyperlipoproteinemia and initial total cholesterol above 7.3 mmol/L (280 mg/dL)
1.8 g6 weeks—
Artichoke leaf extract (Cynara scolymus) reduces plasma cholesterol in otherwise healthy hypercholesterolemic adults: a randomized, double blind placebo controlled trial
2008 · Artichoke leaf extract group · Adults with mild to moderate hypercholesterolemia
1.28 g12 weeks—
Effects of artichoke leaf extract supplementation on metabolic parameters in women with metabolic syndrome: Influence of TCF7L2-rs7903146 and FTO-rs9939609 polymorphisms
2018 · ALE group · Women aged 20–50 years with metabolic syndrome
1.8 g12 weeks—
TCF7L2-rs7903146 polymorphism modulates the effect of artichoke leaf extract supplementation on insulin resistance in metabolic syndrome: a randomized, double-blind, placebo-controlled trial
2018 · ALE group · Patients with metabolic syndrome; age and sex not stated
1.8 g12 weeks—
Artichoke and Bergamot Phytosome Alliance: A Randomized Double Blind Clinical Trial in Mild Hypercholesterolemia
2021 · Supplement group · Adults aged 18–65 years, both sexes, with mild hypercholesterolemia and a previous poor response to bergamot; no history of cardiovascular disease
200 mg60 days30
A new nutraceutical (Livogen Plus®) improves liver steatosis in adults with non-alcoholic fatty liver disease
2022 · Nutraceutical (Livogen Plus®) · Adults aged 30–75 with hepatic steatosis (NAFLD), without diabetes
167 mg12 weeks70